Hazards of thrombolytic therapy for stroke: the real-world experience.
Hurley
J C
JC
D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008485:Medical Audit; D018570:Risk Assessment; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator